Results 251 to 260 of about 823,424 (276)
Background: Faecal microbiota transplantation is an emerging therapeutic option, particularly for the treatment of recurrent Clostridioides difficile infection.
Ed J Kuijper +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Faecal microbiota transplantation is promising but not a panacea
Nature Microbiology, 2016Faecal microbiota transplantation has proved efficacious for diseases such as recurrent Clostridium difficile infection via restoration of gut microbial ecology and bile acid content. However, despite its adoption by mainstream medicine, misuse of this technology in clinical or domestic settings warrants caution.
Michael J, Sadowsky, Alexander, Khoruts
openaire +2 more sources
Faecal microbiota transplantation
BSAVA Companion, 2018Transplanting faecal matter from healthy donors could help provide relief for dogs with chronic diarrhoea and for their owners, volunteers with the StreetVet charity were told at a meeting in London.
openaire +1 more source
Gastrointestinal Nursing, 2012
Faecal microbiota transplant (FMT) is the term used when stool is taken from a healthy individual and instilled into a sick person to cure a certain disease such as recurrent Clostridium difficile infection (CDI). The rationale for FMT lies in the belief that CDI results from an imbalance or disruption of the community of organisms residing in the ...
openaire +1 more source
Faecal microbiota transplant (FMT) is the term used when stool is taken from a healthy individual and instilled into a sick person to cure a certain disease such as recurrent Clostridium difficile infection (CDI). The rationale for FMT lies in the belief that CDI results from an imbalance or disruption of the community of organisms residing in the ...
openaire +1 more source
No benefit of faecal microbiota transplantation for IBS-D
Drug and Therapeutics Bulletin, 2020Abstract Review of: Aroniadis OC, Brandt LJ, Oneto C, et al. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol 2019;4:675–85.
openaire +2 more sources
Faecal microbiota transplantation: Key points to consider
Annales Pharmaceutiques Françaises, 2015Faecal microbiota transplantation (FMT) from a healthy donor has become the gold standard treatment for patients suffering from recurrent Clostridium difficile infection where antibiotic treatment (with vancomycin, metronidazole or fidaxomicin) has failed. FMT eradicates C. difficile and helps restore the recipient's intestinal flora, but its mechanism
openaire +2 more sources
Realising the potential of faecal microbiota transplant
Prescriber, 2023First reported in Western medical literature in the 1950s, faecal microbiota transplant (FMT) has now come of age as a cost‐effective treatment for recurrent Clostridioides difficile infection.
openaire +1 more source
Time to rethink Blastocystis in faecal microbiota transplantation
Trends in ParasitologyBlastocystis commonly colonises the human gut, but its presence has traditionally led to the exclusion of faecal microbiota transplantation donors. Emerging evidence links it to greater microbial diversity and favourable metabolic profiles, while no harm is seen in immunocompetent recipients.
Anders Krifors +3 more
openaire +2 more sources
New guidelines for providing faecal microbiota transplant
Drug and Therapeutics Bulletin, 2019### Key points New guidelines on faecal microbiota transplant from the British Society of Gastroenterology and Healthcare Infection Society provide recommendations to help standardise and optimise the procedure for treating recurrent Clostridium difficile infections.1 A joint British Society of Gastroenterology (BSG) and Healthcare Infection Society
openaire +2 more sources
Faecal microbiota transplantation for urinary tract infections
Clinical Microbiology and InfectionRecurrent urinary tract infections (rUTIs) are a major clinical burden, increasingly complicated by multidrug-resistant organisms (MDROs) and antibiotic overuse. Growing evidence implicates gut microbiota dysbiosis as a key contributor to urinary tract infections (UTI) susceptibility, with the gastrointestinal tract acting as a reservoir for ...
Paulína, Belvončíková +1 more
openaire +2 more sources

